1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RIGEL PHARMACEUTICALS
Rigel Pharmaceuticals XNAS: RIGL

Rigel Pharmaceuticals Live Stock Price Today, Share Analysis and Chart

Strong Performer
about

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...

Read More
41.94 2.06 (5.17%)
Near 52W High of $43.72
714.0K
XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Rigel Pharmaceuticals is on 18 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Affordable Valuation
57.8 / 100
Momentum Score
Technically Bullish
77.4 / 100
Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical aspects which makes them a favourite amongst investors. View Similar Embed DVM
Analyst Price Target
45
1Yr Price target upside is 8%
5 analysts

35

S

4

W

6

O

0

T

SWOT Analysis

Rigel Pharmaceuticals Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..